• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普鲁卡因胺诱发的系统性红斑狼疮及淋巴网状系统疾病。

Procainamide-induced SLE and lymphoreticular disorders.

作者信息

Artinian B, Reesal M

出版信息

Can Med Assoc J. 1974 Feb 2;110(3):314 passim.

PMID:4812149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1947260/
Abstract

A 56-year-old male patient diagnosed as a case of procainamide-induced systemic lupus erythematosus (SLE) was found to have a lymphoproliferative disorder at postmortem examination.Contrary to other immune disorders, the association of SLE with neoplasia is a rare occurrence. The present case raises the question of whether a relationship exists between the lupus diathesis and lymphoreticular neoplasia. The study of the incidence of neoplasia in families of patients with SLE may prove helpful in establishing this relationship.

摘要

一名56岁男性患者被诊断为普鲁卡因胺诱发的系统性红斑狼疮(SLE),尸检发现患有淋巴增生性疾病。与其他免疫疾病不同,SLE与肿瘤形成的关联很少见。本病例提出了狼疮素质与淋巴网状肿瘤之间是否存在关联的问题。研究SLE患者家族中肿瘤的发病率可能有助于确定这种关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/f1f8823fb6c8/canmedaj01575-0076-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/e3bc52c83fe3/canmedaj01575-0075-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/81baaa18b101/canmedaj01575-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/9fa785fe38d6/canmedaj01575-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/f1f8823fb6c8/canmedaj01575-0076-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/e3bc52c83fe3/canmedaj01575-0075-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/81baaa18b101/canmedaj01575-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/9fa785fe38d6/canmedaj01575-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c176/1947260/f1f8823fb6c8/canmedaj01575-0076-c.jpg

相似文献

1
Procainamide-induced SLE and lymphoreticular disorders.普鲁卡因胺诱发的系统性红斑狼疮及淋巴网状系统疾病。
Can Med Assoc J. 1974 Feb 2;110(3):314 passim.
2
Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes.普鲁卡因胺诱发的系统性红斑狼疮。肾脏受累伴免疫复合物沉积。
Arch Pathol Lab Med. 1976 Sep;100(9):469-74.
3
Drug-induced systemic lupus erythematosus.药物性系统性红斑狼疮
Clin Pharm. 1985 Nov-Dec;4(6):657-63.
4
Procainamide-induced systemic lupus erythematosus with hypocomplementemia.普鲁卡因胺诱发的系统性红斑狼疮伴补体减少症。
J Am Geriatr Soc. 1977 May;25(5):230-1. doi: 10.1111/j.1532-5415.1977.tb00304.x.
5
Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.普鲁卡因胺诱发的红斑狼疮中的肾小球肾炎:一例报告及文献复习
J Clin Lab Immunol. 1979 Apr;2(1):79-84.
6
[Acute lupus erythematosus induced by procainamide].[普鲁卡因胺诱发的急性红斑狼疮]
Sem Hop. 1973 Nov 26;49(48):3207-10.
7
[Procainamide- and quinidine-induced immunological changes].[普鲁卡因胺和奎尼丁引起的免疫学变化]
Duodecim. 1977;93(3):206-12.
8
SLE: idiopathic or drug-induced?系统性红斑狼疮:特发性还是药物性?
Geriatrics. 1980 Mar;35(3):81-8.
9
Medication-induced systemic lupus erythematosus.药物性系统性红斑狼疮
Clin Ther. 1992 Jul-Aug;14(4):496-506; discussion 495.
10
Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus.普鲁卡因胺诱发的系统性红斑狼疮患者的临床病理研究
Ann Rheum Dis. 1976 Apr;35(2):181-5. doi: 10.1136/ard.35.2.181.

引用本文的文献

1
The relationship of polluted air and drinking water sources with the prevalence of systemic lupus erythematosus: a provincial population-based study.污染的空气和饮用水源与系统性红斑狼疮患病率的关系:一项省级基于人群的研究。
Sci Rep. 2021 Sep 20;11(1):18591. doi: 10.1038/s41598-021-98111-8.

本文引用的文献

1
L.E. CELLS IN LYMPHOMA.淋巴瘤中的红斑狼疮细胞
Blood. 1963 Aug;22:191-8.
2
Systemic rheumatic disease and malignant lymphoma.系统性风湿性疾病与恶性淋巴瘤。
Arch Intern Med. 1963 Mar;111:330-7. doi: 10.1001/archinte.1963.03620270056009.
3
Studies of relatives of patients with systemic lupus erythematosus.
Arthritis Rheum. 1961 Aug;4:356-63. doi: 10.1002/art.1780040404.
4
Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.同种异体疾病后的恶性淋巴瘤:从免疫性疾病向肿瘤性疾病的转变。
Science. 1965 Sep 24;149(3691):1511-4. doi: 10.1126/science.149.3691.1511.
5
The association of immune disease and malignant lymphoma.免疫性疾病与恶性淋巴瘤的关联。
Ann Intern Med. 1967 Mar;66(3):507-21. doi: 10.7326/0003-4819-66-3-507.
6
Malignant tumours following immunosuppressive therapy.免疫抑制治疗后的恶性肿瘤
Can Med Assoc J. 1970 Dec 19;103(13):1362-5.
7
Drug-induced lupus syndromes.药物性狼疮综合征
Mayo Clin Proc. 1969 Sep;44(9):664-81.
8
Procainamide-induced lupus erythematosus. Clinical and laboratory observations.普鲁卡因胺诱发的红斑狼疮。临床及实验室观察
Am J Med. 1972 Mar;52(3):338-48. doi: 10.1016/0002-9343(72)90021-6.
9
Type I dysgammaglobulinemia, systemic lupus erythematosus and lymphoma.I型免疫球蛋白异常血症、系统性红斑狼疮和淋巴瘤。
Am J Med. 1970 Jan;48(1):113-9. doi: 10.1016/0002-9343(70)90105-1.
10
Appearance of Hodgkin's disease in a patient with systemic lupus erythematosus.系统性红斑狼疮患者出现霍奇金淋巴瘤。
Cancer. 1967 Nov;20(11):1930-3. doi: 10.1002/1097-0142(196711)20:11<1930::aid-cncr2820201121>3.0.co;2-j.